India's Pharmaceutical Exports

Country Profile

Armenia

Armenia is a developing market for Indian pharmaceuticals — $3.80M in FY 2025–26, with 3.9× growth over the past decade. Medicines accounts for 38% of shipments, with vaccines contributing $1.31M. The compound annual growth rate since FY2015 stands at 13.2%.

🇦🇲 $3.80M · 3.9× growth since FY2015 · 13.2% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$3.80M
Exports FY2025–26 DGCIS
3.9×
Growth FY2015→2026
13.2%
CAGR FY2015→2026
38%
Medicines Share
4
Product Categories Supplied
Armenia is a developing market for Indian pharmaceuticals — $3.80M in FY 2025–26, with 3.9× growth over the past decade. Medicines accounts for 38% of shipments, with vaccines contributing $1.31M. The compound annual growth rate since FY2015 stands at 13.2%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $1.44M (38.0%) Vaccines $1.31M (34.6%) Surgical & Hospital Supplies $917K (24.2%) Medicine Ingredients $122K (3.2%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Armenia in the RBI overseas direct investment dataset (2011–2026).